A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia
about
Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian populationPrevention of ER-negative breast cancerVitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.Recent developments in the use of vitamin D analogues.An update on the therapeutic potential of vitamin D analogues.A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyureaVitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitroNovel endocrine therapies in breast cancer.CCAAT enhancer-binding protein alpha is a molecular target of 1,25-dihydroxyvitamin D3 in MCF-7 breast cancer cells.The future of vitamin D analogs.Vitamin D in cancer chemoprevention.p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog.1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma.22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.MCF-7/VD(R): a new vitamin D resistant cell line.Vitamin D3 and calcipotriol enhance the secretion of transforming growth factor-beta 1 and -beta 2 in cultured murine keratinocytes.Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines.22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents.Inhibitory effect of vitamin D3 on 3'methyl-4-dimethyl-amino-azobenzene-induced rat hepatocarcinogenesis: a study on antioxidant defense enzymes.
P2860
Q28344334-059EC7F3-E85F-43D4-BA8F-E118825F2819Q33796968-1D146FB4-601D-4427-A711-36B5F0ACB45DQ33881667-AF2F2035-5639-4AD7-BFFB-C4B48AD224ADQ34074734-46C856C5-7ED8-4E2F-B1A6-3748D733ADE3Q35117084-79DBAD38-D714-47A4-B37C-1F08D8C335C5Q35610145-D94BDC45-A3B3-46A7-AF7B-855CBC479F08Q36294998-8A196C5A-682F-4223-B82F-6A0C29AF8219Q36431217-AC33CD51-87B7-4514-89FD-3018EBA9B6D2Q36859620-8BF9A457-5953-4D26-BCB7-4C97E54FC805Q37075299-03FB7CCD-5F36-478F-8940-C70C42CC35BEQ37695300-BB2772F5-4B07-41BA-A72D-6D1828C7EC72Q38412880-CD5166EC-5D6C-479F-A856-538C5996FC9FQ38855132-AD0E3179-FA65-4CCF-95B4-96EA0411812AQ39610821-0CAE3BFE-97A0-4B9A-892E-E665E9C9149AQ40148790-E2B0E6F9-D72B-43DF-9D20-5B7094EF26C4Q40457024-2823197B-2550-423C-B061-7FA9AC265FBCQ40786680-E9980D70-7388-4814-90C7-91255E1233D5Q41580124-F1A8DD06-6AC4-48FB-A82F-CB2CE65CDCE3Q41873890-4C0D14BE-B0E2-4299-AF89-46216190A805Q42948495-9DFE7365-9177-4D6F-B77B-D1CFC4C368E9Q43706840-765AEF33-6065-45CF-8A9E-4B4D5DBC2ECFQ44204617-13250BB2-4A02-4867-8645-89FD1AA97C6C
P2860
A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia
description
1991 nî lūn-bûn
@nan
1991 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
A novel vitamin D3 analog, 22- ...... without causing hypercalcemia
@ast
A novel vitamin D3 analog, 22- ...... without causing hypercalcemia
@en
A novel vitamin D3 analog, 22- ...... without causing hypercalcemia
@nl
type
label
A novel vitamin D3 analog, 22- ...... without causing hypercalcemia
@ast
A novel vitamin D3 analog, 22- ...... without causing hypercalcemia
@en
A novel vitamin D3 analog, 22- ...... without causing hypercalcemia
@nl
prefLabel
A novel vitamin D3 analog, 22- ...... without causing hypercalcemia
@ast
A novel vitamin D3 analog, 22- ...... without causing hypercalcemia
@en
A novel vitamin D3 analog, 22- ...... without causing hypercalcemia
@nl
P2093
P356
P1433
P1476
A novel vitamin D3 analog, 22- ...... without causing hypercalcemia
@en
P2093
P356
10.1210/ENDO-129-2-832
P407
P577
1991-08-01T00:00:00Z